Clinical trial
Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in…
NCT00612014 · Tranzyme, Inc., Industry · Completed
Key facts
| NCT number | NCT00612014 |
|---|---|
| Title | Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-ranging Study to Assess the Efficacy and Safety of TZP-101 When Administered as a 30 Minute I.V. Infusion to Subjects With Severe Gastroparesis Due to Diabetes Mellitus |
| Lead sponsor | Tranzyme, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastroparesis, Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | 5% dextrose in water, TZP-101 |
| Enrollment | 78 |
| Start date | Oct 1, 2007 |
| Primary completion | Feb 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Feb 11, 2008 |
| Last update posted | Dec 7, 2012 |
| Countries | Denmark, India, Norway, Sweden, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: